Reese Consumer Health™

What Reese Consumer Health™ does

Reese Consumer Health is a fourth-generation, family-owned manufacturer of over-the-counter (OTC) consumer health products, headquartered in Cleveland, Ohio, and tracing its operating history to 1907. The company markets branded OTC SKUs across multiple niche health segments, including Reese's PinWorm Medicine (anti-parasitic), LiceGuard (head lice treatment), ColoTest (home colorectal health screening), and — following a 2026 acquisition — Australian Dream (topical arthritis and joint pain relief). Products are distributed in the United States and Canada through retail OTC channels.

The company operates cGMP-certified, UL-listed, and FDA-registered manufacturing infrastructure, and is in the process of consolidating operations into a new 70,000-square-foot facility in 2026. In parallel with its branded portfolio, Reese runs a private-label and co-manufacturing business, providing formulation, production, and packaging services to retailer-owned and partner brands. Revenue is therefore generated through two streams: branded consumer sales across multiple OTC niches, and contract manufacturing services to B2B customers.

The leadership team combines continuing family stewardship — Jeffrey Reese as President and Casey Reese as EVP — with a professionalized functional bench covering Sales, Finance, Quality, and Operations. There are no disclosed external funding events, and the company operates without an externally validated AI or software platform. Strategic activity has centered on adjacent-category product launches (ColoTest, LiceGuard) and the Australian Dream brand acquisition, signaling measured portfolio expansion within the OTC drug and supplement landscape.

Name

Reese Consumer Health™

Legal name

Reese Consumer Health

Website

https://reeseconsumerhealth.com

Company type

Private

Founded year

1907

Operating status

Operating

Headcount range

11–50 employees

Short description

Reese Consumer Health is a fourth-generation, family-owned OTC health products manufacturer founded in 1907 in Cleveland, Ohio, producing branded and private-label consumer health products for U.S. and Canadian retail markets.

Ownership category

akta.pro rank

Product category

OTC Health Products Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• OTC health products
• Dietary supplements
• Private label manufacturing
• Contract manufacturing
• Consumer health brands

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Branded Consumer Health Products: Sale of proprietary branded OTC health products including ColoTest (colon health testing), Reese's PinWorm Medicine (pinworm treatment), LiceGuard (lice treatment/prevention), and Australian Dream (topical pain relief).
2. Private Label Products: Development and manufacturing of private label consumer health products for pharmacies and retailers, offering first-to-market niche products and products with difficult-to-source ingredients.
3. Contract Manufacturing & Co-packing: Manufacturing and co-packing services for OTC drugs, supplements, and medical devices for partners and retailers, utilizing cGMP-compliant facilities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Reese Consumer Health develops, manufactures, and supplies over-the-counter (OTC) health products and dietary supplements under its own brands — ColoTest®, Reese's PinWorm Medicine, LiceGuard®, and Australian Dream® — while also offering private label manufacturing, contract manufacturing and co-packing, and consumer-insight-driven co-creation services to pharmacies, retailers, and health companies. Operations are anchored in FDA-registered, cGMP-compliant, UL-certified facilities in Cleveland, Ohio.

Product overview

Reese Consumer Health™ is a consumer-first, insight-driven health products company offering a portfolio of branded OTC products alongside private label manufacturing and co-creation services. The company's branded portfolio includes ColoTest® (at-home colon cancer screening), Reese's PinWorm Medicine (No. 1 doctor-recommended pinworm treatment), LiceGuard® (non-toxic lice solutions), and Australian Dream® (FDA-approved topical pain relief acquired in 2026). Complementing its branded products, Reese provides private label manufacturing services and strategic co-creation partnerships for pharmaceutical companies, pharmacies, and retailers seeking to develop and bring next-generation health products to market.

Differentiator

Problem solved

Functional benefit

Brands

• ColoTest®: Colon health self-test kit that detects blood in stool, providing results in minutes without lab testing.
• Reese's Pinworm Medicine
• LiceGuard®
• Australian Dream®

Products and services

• ColoTest®
• Reese's PinWorm Medicine
• LiceGuard®
• Australian Dream® Topical muscle and joint pain relief brand using a unique, FDA-approved histamine-based formula, offering an alternative to menthol- and capsaicin-based pain relievers for arthritis and muscle discomfort, distributed through retail and pharmacy channels.
• Private Label Products
• Co-Creation Services

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Australian DreamcoreOEM/ Whitelabel/ Licensing Partner · 13 August 2026Reese Consumer Health acquired Australian Dream, a topical pain relief brand specializing in arthritis and muscle discomfort products. The acquisition strengthens Reese's position in the OTC pain relief category by adding an established brand with loyal consumer following. Reese plans to leverage its retail relationships and insights to expand Australian Dream's reach across various sales channels.

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Emerging players

• Moberg Pharma: Specialty OTC company focused on topical treatments for skin and pain conditions, including a US topical pain relief portfolio. Comparable niche topical OTC acquisition-and-commercialize strategy.
• Emerson Healthcare: Private OTC and personal care manufacturer focused on niche consumer health products including lice treatment and related categories. Comparable niche OTC portfolio strategy with overlap to Reese's LiceGuard business.
• Insect Shield / Lice Solutions (e.g., Lice Clinics of America franchise system): Specialty players in the lice detection and treatment space using non-toxic approaches. Adjacent competitor to Reese's LiceGuard brand and useful comp for the niche lice treatment category.

Direct peers

• Kramer Laboratories: Private OTC pharmaceutical company marketing niche OTC brands in parasitic and digestive health categories through retail pharmacy. Comparable niche OTC strategy with similar retailer-driven distribution model.
• Prestige Consumer Healthcare: Public OTC consumer health company that owns and markets a portfolio of niche OTC brands across categories including pinworm, lice, and topical pain relief. Highly comparable to Reese's strategy of acquiring and operating established niche OTC brands through retail channels.
• Trifecta Pharmaceuticals: Private OTC manufacturer producing store-brand and branded OTC products (including anti-parasitic, lice, and pain relief categories) for retail and pharmacy chains. Highly comparable contract manufacturer competing for the same private label business as Reese.
• Navajo Manufacturing Company: US private label OTC and personal care contract manufacturer with cGMP facilities, serving drug store and mass-market chains. Comparable scale and business model to Reese's contract manufacturing and private label business.
• Perrigo Company: Largest US private label OTC manufacturer and store-brand supplier, operating cGMP facilities for OTC drugs and supplements sold through pharmacy and retail chains. Closest direct competitor to Reese's private label manufacturing and store-brand OTC business.

Broad incumbents

• Bayer Consumer Health: Global OTC incumbent with leading pain relief (Aleve, Aspercreme), lice, and other OTC brands. Competes with Reese in topical pain relief via Australian Dream and in adjacent OTC categories distributed through the same pharmacy channels.
• Church & Dwight: Large public CPG company with a substantial OTC and consumer health portfolio (e.g., Orajel, Batiste, First Response) sold through the same pharmacy and mass channels as Reese. Broad incumbent competing for the same shelf space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/reese-consumer-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reese Consumer Health™